X

Product Description

Cancyt is indicated for treatment of acute myeloid leukemia, acute lymphoid leukemia, and non-Hodgkin's lymphoma. It is a chemotherapy medicine which is known for having superior effectiveness and targeted mode of action. Cytarabine is present as main chemical in this formulation which shows complete 100% of bioavailability when administered intravenously. It kills fast proliferating cells by interfering with their DNA replication. Cancyt has precise chemical composition and shows more than 95% of protein binding ability with elimination half life of up to 100 hours.

Product details

Minimum Order Quantity

1 Pack

Packaging Type

Injection

Usage

Hospital,Clinical

Dose

5 ml

Packaging Size

1


NEXT GEN BIOTECH

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



Back to top
NEXT GEN BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.